Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

August 11, 2020
Open Access

Modelling the impact of COVID-19 on HIV

The Lancet. HIV
Maia Lesosky, Landon Myer
August 14, 2020

HIV and lymphoma: from oncological futility to treatment

The Lancet. HIV
Ariela Noy
September 4, 2020

The use of disinfection tunnels or disinfectant spraying of humans as a measure to reduce the spread of the SARS-CoV-2 virus

South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde
C L Gray, A Van Niekerk
August 31, 2020

Initiation, discontinuation, and restarting HIV pre-exposure prophylaxis: ongoing implementation strategies

The Lancet. HIV
Sarah E RutsteinMyron S Cohen
July 19, 2020

The History of Wound Healing

The Surgical Clinics of North America
Tiffany Brocke, Justin Barr
July 31, 2020

Gift horse or Trojan horse?

The Lancet. HIV
Rachel M Hilton
September 11, 2020

Perceived HIV stigma and HIV testing among men and women in rural Uganda: a population-based study

The Lancet. HIV
Seth C KalichmanSusan M Kiene
August 9, 2020
Comment / Editorial

Do integrase inhibitors affect immune restoration?

The Lancet. HIV
Christine Katlama, Brigitte Autran
August 7, 2020
Case Report

Urogenital Myiasis Caused by Psychoda spp. in Female Patient with No Risk Factor for Myiasis

Mikrobiyoloji bülteni
Fatma Esenkaya TaşbentEsma Kepenek Kurt
July 6, 2020
Clinical Trial

Decontamination of Gutta-percha Cones employed in Endodontics

Acta Odontológica Latinoamericana : AOL
Clairde S CarvalhoMaria Aal Ferraz
September 6, 2020
Open Access

Data-driven HIV programming to maximise health benefits

The Lancet. HIV
Ruanne V Barnabas, Heidi van Rooyen
July 6, 2020

The effect of different mouthwashes on bacteremia after debonding

Nigerian Journal of Clinical Practice
Y Akbulut
July 23, 2020
Open Access

Awareness and Willingness to Use Biomedical Prevention Strategies for HIV Among Sexual and Gender Minority Youth: Results From a National Survey

The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine
Richard DunvilleStuart Michaels
August 8, 2020
Open Access

PrEP retention and prescriptions for pregnant women during COVID-19 lockdown in South Africa

The Lancet. HIV
Dvora L Joseph DaveyLandon Myer
August 23, 2020
Open Access

Carrageenans as Broad-Spectrum Microbicides: Current Status and Challenges

Marine Drugs
Choongho Lee
September 6, 2020

Converting HIV programmes into chronic-care platforms

The Lancet. HIV
Jennifer Manne-GoehlerTill W Bärnighausen

Sign up to follow this feed and discover related papers.

Related Feeds

AIDS Malignancies

HIV infection increases the risk of non-communicable diseases common in the aged, including cardiovascular disease, neurocognitive decline, non-aids malignancies, osteoporosis, and frailty. Discover the latest research in AIDS malignancies.


Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.


Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.


Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.


An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

© 2020 Meta ULC. All rights reserved